Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Equity Average (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 15 years of Equity Average data on record, last reported at $1.8 million in Q2 2025.

  • For Q2 2025, Equity Average fell 87.71% year-over-year to $1.8 million; the TTM value through May 2025 reached $1.8 million, down 87.71%, while the annual FY2025 figure was $6.3 million, 78.56% up from the prior year.
  • Equity Average reached $1.8 million in Q2 2025 per LFCR's latest filing, down from $8.8 million in the prior quarter.
  • Across five years, Equity Average topped out at $206.3 million in Q1 2021 and bottomed at -$8.9 million in Q3 2023.
  • Average Equity Average over 5 years is $72.3 million, with a median of $34.2 million recorded in 2023.
  • Peak YoY movement for Equity Average: crashed 110.74% in 2023, then soared 194.82% in 2024.
  • A 5-year view of Equity Average shows it stood at $175.0 million in 2021, then crashed by 57.41% to $74.5 million in 2022, then crashed by 108.15% to -$6.1 million in 2023, then skyrocketed by 194.82% to $5.8 million in 2024, then crashed by 69.03% to $1.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Average were $1.8 million in Q2 2025, $8.8 million in Q1 2025, and $5.8 million in Q4 2024.